JPRN-UMIN000002020已完成未知
Specificity of plasma sLOX-1 in emergency patients - Specificity of sLOX-1
ICU, Chiba Hokusoh Hospital, Nippon Medical School0 个研究点目标入组 100 人开始时间: 2009年5月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
sLOX-1 as a markar for early diagnosis of acute myocardial infarctioacute myocardial infarctionJPRN-UMIN000001428ICU, Chiba Hokusoh Hospital, Nippon Medical School30
已完成
3 期
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric CancerGastric CancerNCT02395640Fudan University438
进行中（未招募）
不适用
Xelox-2 in untreated patients with advanced colorectal cancer.A Phase II multicenter study of the gruppo oncologico dell Italia meridionale GOIM - Xelox-2 in treatment of the colorectal cancerpatients with advanced colorectal cancerMedDRA version: 9.1Level: LLTClassification code 10052358Term: Colorectal cancer metastaticEUCTR2006-003270-95-ITGOIM GRUPPO ONCOLOGICO MERIDIONALE
终止
1 期
A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.Uveal MelanomaNCT02601378Novartis Pharmaceuticals107
已完成
2 期
Efficacy and safety of S-1 plus oxaliplatin (C-SOX) as adjuvant chemotherapy for Stage III colon cancer.Colon cancerJPRN-UMIN000012618Kyushu Study group of Clinical Cancer(KSCC)85